Skip to main content

Find Clinical Trials

Home
Conditions
Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant

Clinical trial condition

Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant

Explore clinical trials studying Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant trial results

Completed

Cytochrome P450-2D6 Screening Among Elderly Using Antidepressants (CYSCE)

NCT01778907

Conditions: Behavior, Behavioral Symptoms, Depression, +6 more
Locations: GGZ WNB Halsteren, North Brabant, Netherlands

Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands

Reinier van Arkel groep 's-Hertogenbosch, Netherlands

GGz inGeest Amsterdam, Netherlands

View Trial Details

Completed

Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM

NCT02428660

Conditions: CYP2D6 Polymorphism, Chemically-Induced Disorders, Chronic Disease, +12 more
Locations: VRx Pharmacy Services Salt Lake City, Utah, United States

View Trial Details